Latest filing published 13 Dec 2022 for HTG Molecular Diagnostics, INC, €402.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Laura Lee Godlewski: trading record in brief
All filings by Laura Lee Godlewski on record concern HTG Molecular Diagnostics, Inc, in the capacity of senior executive. Between 10 June 2019 and 9 December 2022, the trades on record add up to 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 December 2022 came the latest disclosure, a share grant for €402 in HTG Molecular Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Laura Lee Godlewski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.4253.5% of flowCommon StockSEC:0001209191-22-061005:0
- 1,000 shares@ US$0.4764.0% of flowCommon StockSEC:0001209191-22-036959:0
- 1,000 shares@ US$3.561551.1% of flowCommon StockSEC:0001209191-21-069778:0
- 672 shares@ US$3.918535.1% of flowCommon StockSEC:0001209191-21-040447:0
4 of 4 declarations